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Summary
What is already known about this subject?
Bivariate choropleth mapping is a way of displaying categories of values
for 2 variables simultaneously on a map. It may be useful for public health
decision making, such as cancer control planning.
What is added by this report?
This report provides a step-by-step guide for developing a bivariate
choropleth map using ArcGIS software, and describes how to interpret the
resultant map.
What are the implications for public health practice?
The development and use of these maps can guide allocation of re-
sources and targeting of interventions to areas of greatest need.
Abstract
Bivariate choropleth mapping is a straightforward but underused
method for displaying geographic health information to use in
public health decision making. Previous studies have recommen-
ded this approach for state comprehensive cancer control planning
and similar efforts. In this method, 2 area-level variables of in-
terest are mapped simultaneously, often as overlapping quantiles
or by using other classification methods. Variables to be mapped
may include area-level (eg, county level) measures of disease bur-
den,  health  care  use,  access  to  health  care  services,  and  so-
ciodemographic characteristics. We demonstrate how geographic
information systems software, specifically ArcGIS, can be used to
develop bivariate choropleth maps to inform resource allocation
and public health interventions. We used 2 types of county-level
public health data: South Carolina’s Behavioral Risk Factor Sur-
veillance System estimates of ever having received cervical can-
cer screening, and a measure of availability of cervical cancer
screening providers that are part of South Carolina’s Breast and
Cervical  Cancer  Early  Detection  Program.  Identification  of
counties with low screening rates and low access to care may help
inform where additional resources should be allocated to improve
access  and  subsequently  improve  screening  rates.  Similarly,
identifying counties with low screening rates and high access to
care may help inform where educational and behavioral interven-
tions should be targeted to improve screening in areas of high ac-
cess.
GIS Mapping to Inform Cancer
Prevention and Control Efforts
Mapping by using geographic information systems (GIS) has been
used extensively to inform resource allocation and to evaluate ac-
cess to health care services, including cancer screening (1–4). By
using area-level data, one can map estimates or rates of cancer risk
factors; cancer screening use, incidence, and mortality; and access
to cancer prevention, screening, and treatment services. Under-
standing the geographic distribution of cancer-related risk factors
and outcomes can inform interventions by identifying areas of
greatest burden of disease and greatest scarcity of services (5).
Bivariate mapping has been proposed as an effective GIS-based
approach for disease surveillance and state-level public health pro-
gramming broadly and cancer control planning specifically (6–9).
This approach uses choropleth mapping (ie, a thematic map where
areas are colored to represent data values) to display 2 variables
simultaneously among geographic units such as states or counties
by creating “n × n” groupings where values of both variables inter-
sect. State-level studies have used bivariate mapping to examine
lung cancer mortality relative to access to lung cancer screening,
racial disparities in 2 types of cancer screening, late-stage rates of
2 cancers, and other cancer-related data (6,10–13). Overall, bivari-
ate mapping is underused in cancer control, especially at the sub-
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state level (eg, counties). Applying this mapping approach within
states may inform resource allocation and program planning. Our
objective was to describe potential applications of bivariate map-
ping and provide step-by-step guidance for its implementation us-
ing GIS software to inform cancer prevention and control.
Uses of Bivariate Choropleth Mapping in
Cancer Prevention and Control
Data can be mapped in several ways for cancer prevention and
control purposes by using public health surveillance, program-
ming, policy, and other data (Table 1).  Such data may include
availability of public health programming locations and of screen-
ing and/or safety net providers, state-level policies, population-
level rates of screening use, cancer incidence, staging rates, and/or
mortality (7,10,14,15). Such data are generally accessible to state
and local public health departments from sources like the Behavi-
oral Risk Factor Surveillance System (BRFSS), cancer registries,
Robert Wood Johnson Foundation County Health Rankings, and
vital statistics systems. Bivariate mapping will be most appropri-
ately implemented using state- and county-level data. Because of
limitations in the availability of more geographically granular data
and the subsequent challenges of calculating stable rates from
sparse data,  bivariate mapping at geographically smaller units,
such as ZIP codes or census tracts, is not recommended. Bivariate
maps are either 2×2 or 3×3 maps. Maps in 2×2 format allow for
readability in both full-color and gray scale; 3×3 maps are read-
able only in color but allow for greater variability in values of dis-
played variables.
Cervical Cancer Screening Example:
Public Health Programing and
Surveillance Data
To show how this tool is implemented, we mapped availability of
cervical cancer screening providers in South Carolina’s Breast and
Cervical Cancer Early Detection Program (BCCEDP) (16) and es-
timates of ever having had a Pap test among women aged 18 or
older from BRFSS at the county level. The BCCEDP program and
the BRFSS survey are administered by the state public health de-
partment (17). This example uses readily (and often publicly avail-
able) data, but we encourage those who implement this method to
be sensitive to data use agreements and stipulations for aggrega-
tion and scale of geographic scale of data presentation.
South Carolina’s Breast and Cervical Cancer Early Detection Pro-
gram. South Carolina’s BCCEDP provides eligible women with
free breast and cervical cancer screening and other services (16).
South Carolina women aged younger than 65, who have no insur-
ance or are underinsured, and who meet income requirements are
eligible  for  these  services.  To  be  eligible  for  cervical  cancer
screening, women must be aged 21 to 64 (18).
Behavioral Risk Factor Surveillance System.  BRFSS is a tele-
phone-based questionnaire that assesses risk behaviors, chronic
health conditions, and use of preventive services (19). The survey
is mandated by the Centers for Disease Control and Prevention
(CDC) and is administered annually at the state level. Annual sur-
veys include core questions, but states can add optional modules
on salient health concerns. BRFSS routinely surveys participants
about cervical, breast, and colorectal cancer screening and about
cancer-related health behaviors. Optional modules are available on
cancer-relevant health care use such as human papilloma virus
(HPV) vaccination, lung cancer screening, and cancer survivor-
ship. In our example, we used South Carolina county-level estim-
ates of the percentage of women aged 18 or older who had ever re-
ceived a Papanicolaou (Pap) test. The state public health depart-
ment provided these estimates, which were generated by combin-
ing responses from 2012, 2014, and 2016 data to maximize sample
sizes. However, 3 counties did not have sufficient sample size for
stable rates, that is, data were suppressed if the denominator was
less than 50 or the 95% confidence interval range was greater than
20%. We also obtained county-level estimates of the percentage of
women of recommended screening age (18–65 y) who met the US
Preventive Services Task Force screening recommendation for a
Pap test (a screening within the past 3 years), but data were sup-
pressed for 9 South Carolina counties (20%), making it an inad-
equate measure for bivariate mapping (18).  Although we used
crude estimates in our example, age-adjusted estimates are fre-
quently used by public health professionals and may be useful for
bivariate mapping.
An Overview of Bivariate Choropleth
Mapping Creation in ArcGIS
We show how ArcGIS (Esri), a widely used GIS software pro-
gram, can create bivariate choropleth maps for cancer prevention
and control — such as by displaying Pap test use rates and wo-
men’s access to cervical cancer screening providers, as we do in
our demonstration. Although analysts may use various GIS pro-
grams, we used ArcGIS in our example because it is the software
used in CDC’s GIS training curriculum for chronic disease (20). In
particular, the analyst will implement the following tools in the
ArcGIS toolbox and functions in the layer properties and attribute
tables: the “spatial join” tools within the ArcGIS toolbox, “sym-
bology” function within layer properties, and “adding and calcu-
lating new fields” functions in attribute tables. Additional render-
ing tools are available to implement bivariate mapping in ArcGIS
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or other GIS software,  but we present our example to develop
bivariate maps without additional components (21). Furthermore,
we present an example that requires additional, intermediate GIS
skills (eg, spatial joins). However, depending on the data that the
analyst wants to map, such skills may not be needed to implement
this method. The following 7 steps describe the process of creat-
ing bivariate choropleth mapping in ArcGIS:
1. Obtain point and area-level data and shapefiles, (a file format
that stores the geometric location and other information about geo-
graphic features — polygons/counties, in this case). The analyst
obtains necessary data and shapefiles for implementation. In our
example, this includes:
Address data from the state public health department on BCCEDP cervical
cancer screening providers, obtained from the South Carolina BCCEDP man-
ager;
•
Area-level (ie, county-level) data on estimates of “ever having had a Pap
test” among women aged 18 or older, from the state’s BRFSS coordinator;
•
County-level data on the number of women aged 18 to 64 in South Carolina
who are uninsured, from the American Community Survey’s Model-Based
Small-Area Health Insurance Estimates (SAHIE) for 2017 (22); and
•
County-level Topographically Integrated Geographic Encoding and Referen-
cing (TIGER) cartographic boundary shapefiles from the US Census Bureau
(23).
•
2. Perform data management steps for all data types. The analyst
will perform data management steps for all aforementioned data
and shapefiles. In our example, this includes:
Geocode address data for BCCEDP cervical cancer screening providers that
uses the World Geocoding Service (or appropriate address locator file) ac-
cessible within ArcGIS, and display these points; and
•
Add county-level BRFSS and SAHIE data and TIGER shapefile as layers with-
in ArcGIS, and join area-level data to the shapefile on a linking variable such
as Federal Information Processing Standard (FIPS) county codes.
•
3. Calculate county-level availability of BCCEDP cervical cancer
screening providers.  Geocoded data  can be  used to  determine
availability and accessibility of health care services, including ser-
vice density and area-level travel distance and/or time. We demon-
strate the calculation of a service density measure that does not re-
quire the use of the spatial analyst tools or the Network Analyst
extension. Furthermore, service density measures are more appro-
priate for larger geographic units, like counties. The analyst will
employ the “spatial join” tool within the Analysis ArcGIS tool to
sum the number of geocoded points (ie, BCCEDP cervical cancer
screening providers) in each county. The target feature will be the
TIGER county shapefile,  and the join feature will  be the geo-
coded table of points. Within this tool, use a “join one to one” join
operation by using the “completely contains” match option. Cre-
ate a county field and perform a spatial join between the geocoded
data and the shapefile. From this joined file, the analyst will add a
new field and calculate a new “double” (numeric) variable. This
variable  will  be  the  summed count  of  BCCEDP providers  by
county divided by the count of uninsured women aged 18 to 64 in
the county.  This  age grouping is  the closest  approximation of
BCCEDP eligibility from SAHIE data. We re-scaled this provider-
to-population ratio by multiplying by 10,000. This new variable,
the second variable of interest, will act as a measure of availabil-
ity of BCCEDP cervical cancer screening providers relative to a
proxy measure of eligibility (women who meet age and insurance
status criteria).
4. Determine the number of bivariate classes per variable and clas-
sification method and create choropleth maps for each variable.
The analyst will explore the distribution of both variables, county-
level estimates of “ever having a Pap test,” and county-level avail-
ability of BCCEDP providers of cervical cancer screening by us-
ing the symbology function under properties for the layer of in-
terest. For this example, 3 counties lack stable rates for Pap test
use. These counties should not be considered in the classification
scheme and should be selected as a new layer so that they can be
displayed as null values, which we display with crosshatches (Fig-
ure 1). Recognizing the strengths and limitations of different clas-
sification methods (eg, quantile, natural breaks, manual) (Table 2),
the analyst should test different classification methods and exam-
ine the distribution of values for each variable (24–26). The ana-
lyst should consider the number of classes that will be most appro-
priate for the variables of interest, the number of polygons (ie,
counties)  displayed,  and implications for  uses of  the resultant
bivariate map. For ease in display and interpretation, we recom-
mend that there be no more than 3 classes per variable (ie, 9 total
combinations). In our example, we tested 2 classification methods
(natural breaks and quantiles) with 3 categories for both variables
(Figure 1). Natural breaks classification maximizes the difference
between classes while minimizing the differences within classes,
but there can be wide variation in the number of counties in each
class. Quantile (tertiles in this case) classification ensures that each
class  has  an  equal  number  of  counties,  but  it  also  means  that
counties with similar values may be assigned to different categor-
ies. However, quantile classification is also more intuitive for lay
audiences and can be helpful for indicating the relative disease
burden or access scarcity for different areas, which is important
when considering  the  allocation  of  finite  resources.  Thus,  we
chose this classification method for our example.
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Figure 1.  Choropleth maps displaying different classification methods for
Papanicolaou (Pap) test use and Breast and Cervical Cancer Early Detection
Program (BCCEDP) cervical cancer screening availability. Map A, Pap test use
with 3 natural breaks classification; Map B, BCCEDP cervical cancer screening
availability using 3 natural breaks classification; Map C, Pap test use using
quantile (tertile) classification; Map D, BCCEDP availability using quantile
(tertile) classification.
5. Categorize variable combinations accordingly. For each vari-
able (in this example, Pap test use and BCCEDP availability), cre-
ate a new “tertile” variable for each variable in the attribute table,
representing low, medium, and high values. This can be achieved
by, for example, “selecting by attribute” for the variable of in-
terest and selecting all values in the lowest tertile. When counties
with these values are selected, use the “calculate” function to as-
sign the tertile group for the new variable. Repeat this for each ter-
tile grouping for both new variables. The new variable should now
have 3 values reflected in each:  1,  2,  3 or  low, medium, high,
whichever naming scheme is more intuitive. From these 2 new
variables, create a third new variable within the attribute table
again by using the “select by attribute” function to create 9 values
based on the combination of values from the 2 new tertile groups:
High access/high use1.
High access/medium use2.
High access/low use3.
Medium access/high use4.
Medium access/medium use5.
Medium access/low use6.
Low access/high use7.
Low access/medium use8.
Low access/low use9.
In total, we created the following county-level variables in steps 3
to 5: 1) availability of BCCEDP cervical cancer screening pro-
viders  (step  3);  2)  BRFSS  Pap  test  use  tertiles  (step  5);  3)
BCCEDP availability tertiles (step 5); and BRFSS Pap test and
BCCEDP tertile overlap (step 5).
6. Assign a visually distinguishable color scheme and legend for a
bivariate map. Because nine colors will be displayed, it is import-
ant that the hues symbolizing the values of the new bivariate vari-
able be visually distinguishable. We suggest that analysts use the
Color Brewer website (27) or refer to suggested color schemes
from Joshua  Stevens  (28).  We provide  an  example  of  a  color
palette and legend in Figure 2. This figure is overlaid with the red,
green, blue (RGB) color codes for each respective color displayed
to allow the analyst to modify the fill colors for their maps within
the symbol selector function. We created our legend in Microsoft
PowerPoint, but an .mxd file is available for download to create a
bivariate legend (21). In displaying these values, we suggest that
the analyst designate the grouping with the worse outcome or ac-
cess in the darkest  color  hue.  In our  example,  this  will  be the
counties with the lowest BCCEDP availability and the lowest Pap
test use rate. For maps that display disease burden, the counties
with the highest values should be displayed in the darkest color
hue. We also recommend that users review best practices for map-
ping cancer data by including relevant elements: title, legend, la-
bels, and other information as needed (5). Best practices include
development of a descriptive title, a clear legend, and helpful geo-
graphic and data labels (eg, county names). The final map, for ex-
ample, is displayed in Figure 3.
Figure 2. Sample 3×3 bivariate map legend displaying visually distinguishable
color scheme  with red, green, blue color (RGB) codes displayed.
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Figure 3.  Bivariate  map displaying Pap test  use and Breast  and Cervical
Cancer Early Detection Program cervical cancer screening availability with
color-coded legend. (Counties with hatch marks had insufficient data to map.)
7. Interpret bivariate map for cancer prevention and control applic-
ation. After the bivariate map has been developed with the appro-
priate elements, analysts can interpret the map. In our example
map (Figure  3),  we identified that  counties  (Oconee,  Pickens,
Greenville, and Anderson) in the northwestern-most part of the
state and Colleton and Charleston counties in the southeastern-
most part of the state fell into the low-access/low-use group, sug-
gesting that these counties may be important targets for increased
resource allocation or physician engagement to improve the num-
ber of BCCEDP providers relative to the population in need of
such services. Additionally, counties with high access but low use
(Saluda, Florence, and Dillon) may be important targets for educa-
tional interventions, because services are available but are not be-
ing used sufficiently. Such information may be helpful for state
public health departments to help allocate resources and imple-
ment interventions, and for nonprofit organizations as they advoc-
ate for increased resources. Of note, 3 counties had null values be-
cause they had insufficient data on Pap test use.
Strengths and Limitations of Bivariate
Mapping for Cancer Prevention and
Control
The strength of the GIS mapping approach is that it is easy to im-
plement for users with an intermediate GIS skill set and is ideal
for the display of sub-state variables that are often readily avail-
able from federal or state public health surveillance systems and
programs. Furthermore, it allows for the display of 2 variables
simultaneously using a single-color scheme. Additionally, the res-
ultant bivariate map provides useful information for public health,
nonprofit groups, and other stakeholders who want to identify geo-
graphic targets for resource allocation decisions and intervention
planning. In our experience, geographic mapping is received posit-
ively in both lay and scientific communities, especially over typic-
al numerical presentations (tables of rates or percentages). It al-
lows the audience to quickly and easily identify problem areas.
However,  this  method is  not  without  its  limitations.  First,  al-
though users may implement the classification method most ap-
propriate for their data and map use, each method has its strengths
and weaknesses, which users will have to weigh when creating
such maps. Second, display of county-level surveillance data of-
ten yields suppressed data because of unstable rates in sparsely
populated rural counties. Thus, some counties may not have suffi-
cient data for bivariate mapping, as in Figure 3. However, this
problem can be mitigated through implementation of rate smooth-
ing or small-area estimation approaches if the analyst has access to
nonaggregated data and appropriate statistical training (29–31).
Similarly,  displaying spatial  access  to  care  by using a  service
density approach, as we do in this example, has limitations. This
approach does not indicate where screening providers are located
within a county. It also assumes people have access to or seek care
only within their county. More rigorous GIS approaches that con-
sider  distance  to  health  care  services  and  seeking  health  care
across county boundaries are typically implemented at smaller
geographic scales (zip codes or census tracts), for which it is diffi-
cult to provide area-level rates or estimates of health care use or
disease burden.
Conclusions
Implementing bivariate mapping approaches to simultaneously
display 2 relevant variables is an effective, but underused method
to inform cancer prevention and control efforts. Applied to cancer
control planning, this method can display surveillance data on risk
factors, screening, incidence, and mortality and data on socioeco-
nomic factors or availability and accessibility of health care re-
sources. GIS users can implement a straightforward set of data
management and symbology steps in ArcGIS to develop bivariate
maps. The resultant maps can be interpreted to inform allocation
of resources, geographic targeting of interventions, and advocacy
efforts to inform cancer prevention and control efforts.
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Tables
Table 1. Examples of Public Health Data Uses for Bivariate Mapping in Cancer Prevention and Control
Variable Combination Examples Application
Availability of public health programs to
improve prevention or early detection of
cancer
1.
Population-level use of a cancer screening2.
Number of Breast and Cervical Cancer Early
Detection Program providers within a county relative
to potentially program-eligible women
1.
County-level estimates of breast and/or cervical
cancer use
2.
Identification of geographic areas with low availability of
Program providers and low screening rates may reveal
important areas to engage additional providers to
become involved in the Program.
Accessibility of screening providers1.
Population-level rates of cancer incidence,
staging, or mortality
2.
Accessibility of lung cancer screening centers
relative to the population of recommended
screening age (10)
1.
County-level age-adjusted lung cancer mortality2.
Identification of areas with low access to screening and
high disease burden may help communicate to policy
makers where public health resources should be
targeted and help health systems to identify new
potential screening locations.
Accessibility of primary care providers1.
Population-level rates of cancer incidence,
staging, or mortality
2.
Accessibility of federally qualified health centers1.
Mortality-to-incidence ratios2.
Identification with high disease burden relative to low
access to primary care services for underserved
populations.
Exposure-attributable disease rates1.
Population-level health behaviors2.
County-level radon-attributable lung cancer mortality
rates (7)
1.
County-level smoking rates2.
Identification of areas with particularly high risk of
disease due to multiple exposures may be cost-effective
targets for public health interventions.
Cancer incidence or mortality in
population group #1
1.
Cancer incidence or mortality in
population group #2
2.
Breast cancer mortality among non-Hispanic white
women
1.
Breast cancer mortality among non-Hispanic black
women
2.
Identification of particularly stark relative racial
disparities may be important geographic targets for
states to consider when integrating health equity
components into their comprehensive cancer control
plans (14).
Cancer screening use1.
Health policy2.
State-level colorectal cancer screening use (15)1.
State-level Medicaid expansion status (15)2.
Identify areas where lower rates of screening use may
be affected by state-level policy decisions.
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Table 2. Classification Methods for Choropleth Maps
Method Definition Strengths Weaknesses
Natural breaks (Jenks) Similar values within classes, maximize
differences between classes
Explicitly reflects distribution of values•
Does not arbitrarily place observations with
similar values into different groups
•
Classes do not have equal ranges or equal
number of observations
•
Can’t compare across maps•
Equal interval The range of values (the maximum
value minus the minimum value)
divided into a fixed number of classes
Facilitates comparisons across maps•
Intuitive•
Best applied for percentages and
temperatures
•
Not good for skewed data•
Quantiles Equal frequency of values within each n
class (eg, tertiles, quartiles)
Ensures each class has an equal number of
areas represented
•
Better than the equal interval method for
skewed data
•
Intervals are usually dissimilar in size•
Similar values may be placed in different
classes
•
z score/standard
deviation
Values are converted to z scores
indicating deviation from the mean
Good for comparison of maps (ie, same
metric)
•
Useful with normally distributed data•
Are not in the units of the values•
May be less intuitive for lay audiences•
Manual Classes are determined by the analyst
(eg, at or above a certain value of
interest such as a Healthy People 2020
objective)
Meaningful for audience• Arbitrary•
Often not statistically driven•
Classless Continuous values varying by intensity
of color shading
Shows variation more accurately• May be difficult to distinguish values
across large areas
•
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